oxidopamine has been researched along with Hypertrophy in 9 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Hypertrophy: General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Intermittent L-DOPA treatment induced hypertrophy of the lesioned-side of medial globus pallidus and substantia nigra reticulata of 6-hydroxydopamine-lesioned rats with behavioral sensitization to L-DOPA." | 1.32 | Hypertrophy of medial globus pallidus and substantia nigra reticulata in 6-hydroxydopamine-lesioned rats treated with L-DOPA: implication for L-DOPA-induced dyskinesia in Parkinson's disease. ( Baba, M; Ichinohe, N; Kimura, T; Matsunaga, M; Mori, F; Tomiyama, M; Wakabayashi, K, 2004) |
| "Captopril was given (30 or 100 mg kg(-l) day(-l); p." | 1.31 | Angiotensin converting enzyme inhibition prevents trophic and hypertensive effects of an antagonist of adenosine receptors. ( Albino-Teixeira, A; Morato, M; Sousa, T, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Sahbaie, P | 1 |
| Li, WW | 1 |
| Guo, TZ | 1 |
| Shi, XY | 1 |
| Kingery, WS | 1 |
| Clark, JD | 1 |
| Tomiyama, M | 1 |
| Mori, F | 1 |
| Kimura, T | 1 |
| Ichinohe, N | 1 |
| Wakabayashi, K | 1 |
| Matsunaga, M | 1 |
| Baba, M | 1 |
| Gomide, V | 1 |
| Bibancos, T | 1 |
| Chadi, G | 1 |
| Miklyaeva, EI | 1 |
| Whishaw, IQ | 1 |
| Kolb, B | 1 |
| Chakraborty, S | 1 |
| Maitra, SK | 1 |
| Curry, TE | 1 |
| Lawrence, IE | 1 |
| Burden, HW | 1 |
| Gerendai, I | 1 |
| Nemeskéri, A | 1 |
| Csernus, V | 1 |
| Heumann, R | 1 |
| Goemans, C | 1 |
| Bartsch, D | 1 |
| Lingenhöhl, K | 1 |
| Waldmeier, PC | 1 |
| Hengerer, B | 1 |
| Allegrini, PR | 1 |
| Schellander, K | 1 |
| Wagner, EF | 1 |
| Arendt, T | 1 |
| Kamdem, RH | 1 |
| Obst-Pernberg, K | 1 |
| Narz, F | 1 |
| Wahle, P | 1 |
| Berns, H | 1 |
| Sousa, T | 1 |
| Morato, M | 1 |
| Albino-Teixeira, A | 1 |
9 other studies available for oxidopamine and Hypertrophy
| Article | Year |
|---|---|
Autonomic Regulation of Nociceptive and Immunologic Changes in a Mouse Model of Complex Regional Pain Syndrome.
Topics: Animals; Autonomic Nervous System; Chronic Pain; Complex Regional Pain Syndromes; Disease Models, An | 2022 |
Hypertrophy of medial globus pallidus and substantia nigra reticulata in 6-hydroxydopamine-lesioned rats treated with L-DOPA: implication for L-DOPA-induced dyskinesia in Parkinson's disease.
Topics: Animals; Dyskinesias; Globus Pallidus; Hypertrophy; Levodopa; Male; Oxidopamine; Parkinson Disease; | 2004 |
Dopamine cell morphology and glial cell hypertrophy and process branching in the nigrostriatal system after striatal 6-OHDA analyzed by specific sterological tools.
Topics: Animals; Antibodies; Biomarkers; Cell Count; Cell Shape; Corpus Striatum; Denervation; Dopamine; Gli | 2005 |
A golgi analysis of cortical pyramidal cells in the unilateral parkinson rat: absence of change in the affected hemisphere vs hypertrophy in the intact hemisphere.
Topics: Animals; Apomorphine; Cerebral Cortex; Dendrites; Dendritic Spines; Dextroamphetamine; Female; Forel | 2007 |
Stress factors can reverse the pinealostimulatory effect of 6-hydroxydopamine on the pineal gland of blossomheaded parakeet (Psittacula cyanocephala).
Topics: Animals; Cell Nucleus; Hydroxydopamines; Hypertrophy; Male; Oxidopamine; Parakeets; Pineal Gland; Ps | 1982 |
Effect of ovarian sympathectomy on follicular development during compensatory ovarian hypertrophy in the guinea-pig.
Topics: Animals; Castration; Female; Guinea Pigs; Hydroxydopamines; Hypertrophy; Ovarian Follicle; Ovary; Ox | 1984 |
Depending on the dose 6-OHDA stimulates or inhibits the testis of immature rats.
Topics: Animals; Animals, Newborn; Castration; Dose-Response Relationship, Drug; Female; Hydroxydopamines; H | 1984 |
Transgenic activation of Ras in neurons promotes hypertrophy and protects from lesion-induced degeneration.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Axotomy; Brain; | 2000 |
Angiotensin converting enzyme inhibition prevents trophic and hypertensive effects of an antagonist of adenosine receptors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Blood Pressure; Body Weight; Captopril; | 2002 |